Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,048 | -6,584 | -29,706 | -5,904 | -4,666 |
| Depreciation Amortization | 1,239 | 1,538 | 1,495 | 779 | 237 |
| Accounts receivable | -182 | -3 | -56 | -32 | -50 |
| Other Working Capital | -119 | 128 | -216 | -462 | 568 |
| Other Operating Activity | 2,173 | 3,096 | 25,942 | 3,620 | 3,959 |
| Operating Cash Flow | $-2,937 | $-1,826 | $-2,540 | $-1,999 | $48 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122 | -31 | -3 | -23 | N/A |
| Purchase Sale Intangibles | N/A | -25 | N/A | -306 | N/A |
| Other Investing Activity | 0 | -25 | 0 | -306 | 0 |
| Investing Cash Flow | $-122 | $-56 | $-3 | $-328 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 750 | 1,660 | 2,714 | 235 |
| Debt Repayment | -675 | N/A | -188 | -564 | -116 |
| Common Stock Issued | 6,100 | 1,400 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | 940 | 100 | N/A |
| Financing Cash Flow | $5,425 | $2,150 | $2,412 | $2,250 | $119 |
| Beginning Cash Position | 280 | 11 | 143 | 220 | 53 |
| End Cash Position | 2,646 | 280 | 11 | 143 | 220 |
| Net Cash Flow | $2,366 | $268 | $-131 | $-78 | $167 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,937 | -1,826 | -2,540 | -1,999 | 48 |
| Capital Expenditure | -123 | -31 | -3 | -23 | N/A |
| Free Cash Flow | -3,060 | -1,856 | -2,543 | -2,022 | 48 |